Florence Marteau

520 total citations
30 papers, 356 citations indexed

About

Florence Marteau is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Florence Marteau has authored 30 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Florence Marteau's work include Renal cell carcinoma treatment (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Florence Marteau is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Florence Marteau collaborates with scholars based in France, United States and United Kingdom. Florence Marteau's co-authors include Dan J. Stein, Mark Legault, Eric Hollander, Naomi Fineberg, Steven Marwaha, Paul Bebbington, Mondher Toumi, Azorin Jm, Matthias C. Angermeyer and Bruno Daniele and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Clinical Psychiatry.

In The Last Decade

Florence Marteau

30 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Florence Marteau France	10	93	89	81	62	58	30	356
Maria Alejandra Luna‐Cuadros United States	7	36 0.4×	120 1.3×	77 1.0×	39 0.6×	22 0.4×	9	431
Suraj Samtani Australia	10	95 1.0×	85 1.0×	36 0.4×	40 0.6×	11 0.2×	31	332
Liliana Gazzuola Rocca United States	13	37 0.4×	15 0.2×	75 0.9×	39 0.6×	19 0.3×	30	535
Vikram Lele India	10	101 1.1×	62 0.7×	67 0.8×	26 0.4×	37 0.6×	43	406
Victor Gheorman Romania	10	47 0.5×	28 0.3×	32 0.4×	33 0.5×	19 0.3×	52	363
M.-A. Pierredon France	6	71 0.8×	17 0.2×	14 0.2×	98 1.6×	8 0.1×	9	370
J. Setoain Spain	10	65 0.7×	13 0.1×	18 0.2×	74 1.2×	11 0.2×	22	403
Michelle Stewart United States	11	67 0.7×	61 0.7×	49 0.6×	124 2.0×	18 0.3×	26	545

Countries citing papers authored by Florence Marteau

Since Specialization

Citations

This map shows the geographic impact of Florence Marteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Marteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Marteau more than expected).

Fields of papers citing papers by Florence Marteau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Marteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Marteau. The network helps show where Florence Marteau may publish in the future.

Co-authorship network of co-authors of Florence Marteau

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Marteau. A scholar is included among the top collaborators of Florence Marteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Marteau. Florence Marteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trojan, Jörg, Patrick Mollon, Bruno Daniele, et al.. (2021). Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison. Advances in Therapy. 38(5). 2472–2490. 11 indexed citations

Shaunfield, Sara, Kimberly Webster, Karen Kaiser, et al.. (2020). Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index. Neuroendocrinology. 111(9). 850–862. 4 indexed citations

Kelley, Robin Kate, Patrick Mollon, Jean‐Frédéric Blanc, et al.. (2020). Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma. Advances in Therapy. 37(6). 2678–2695. 45 indexed citations

Harrow, B., et al.. (2020). PDG12 In the Current COVID Reality, CAN Independent Injection of Somatostatin Snalogues Lead to Greater Health Savings? a Budget IMPACT Analysis in the UK. Value in Health. 23. S522–S523. 1 indexed citations

Maschio, Michael, Michele Kohli, Simron Singh, et al.. (2020). A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome. PharmacoEconomics. 38(6). 607–618. 3 indexed citations

Chen, Ronald C., Toni K. Choueiri, Jie Meng, et al.. (2020). Quality‐adjusted survival with first‐line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance). Cancer. 126(24). 5311–5318. 12 indexed citations

Schmidt, Elvira, J. Lister, Witold Więcek, et al.. (2018). Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis. Targeted Oncology. 13(2). 205–216. 8 indexed citations

Gakis, Georgios, et al.. (2018). Kosten-Effektivitäts-Analyse zur Verwendung der Blaulichtzystoskopie mit Hexylaminolevulinat bei der transurethralen Resektion der Harnblase. Der Urologe. 58(1). 34–40. 3 indexed citations

Cella, David, Jennifer L. Beaumont, Stacie Hudgens, et al.. (2018). Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR. Clinical Therapeutics. 40(12). 2006–2020.e2. 27 indexed citations

10.

Björstad, Åse, Thomas Marlow, Eva Lesén, et al.. (2017). Real-World Resource Use And Costs of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors: A Retrospective Swedish Study. Value in Health. 20(9). A552–A552. 1 indexed citations

11.

Maschio, Michael, Simron Singh, D. Mark Pritchard, et al.. (2017). A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome. Value in Health. 20(9). A548–A549. 2 indexed citations

12.

Jabłonowski, Zbigniew, et al.. (2015). Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland. Value in Health. 18(7). A360–A360. 1 indexed citations

13.

Marteau, Florence, et al.. (2014). Epidemiology of Patients with Metastatic Castrate Resistant Prostate Cancer in Europe and Australia. Value in Health. 17(7). A619–A619. 5 indexed citations

14.

Marteau, Florence, et al.. (2013). Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer. Value in Health. 16(7). A408–A409. 2 indexed citations

15.

Nordström, G., Natalya Danchenko, Nicolas Despiégel, & Florence Marteau. (2012). Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder. Value in Health. 15(2). 231–239. 7 indexed citations

16.

Nuijten, Mark, Mélanie Brignone, Florence Marteau, Johan A. den Boer, & Erik Hoencamp. (2012). Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting. Clinical Therapeutics. 34(6). 1364–1378. 9 indexed citations

17.

Nordström, G., Nicolas Despiégel, Florence Marteau, Natalya Danchenko, & Khaled Maman. (2010). Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden. Journal of Medical Economics. 13(3). 516–526. 10 indexed citations

18.

Hollander, Eric, Dan J. Stein, Naomi Fineberg, Florence Marteau, & Mark Legault. (2010). Quality of Life Outcomes in Patients With Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. 71(6). 784–792. 82 indexed citations

19.

Bebbington, Paul, Matthias C. Angermeyer, Azorin Jm, et al.. (2008). Side‐effects of antipsychotic medication and health‐related quality of life in schizophrenia. Acta Psychiatrica Scandinavica. 119(s438). 22–28. 55 indexed citations

20.

Marteau, Florence, et al.. (2008). Approche critique du développement des schémas en psychopathologie cognitive. Journal de Thérapie Comportementale et Cognitive. 18(2). 57–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Alejandra Luna‐Cuadros Breakdown of academic impact, for papers by Suraj Samtani Breakdown of academic impact, for papers by Liliana Gazzuola Rocca Breakdown of academic impact, for papers by Vikram Lele Breakdown of academic impact, for papers by Victor Gheorman Breakdown of academic impact, for papers by M.-A. Pierredon Breakdown of academic impact, for papers by J. Setoain Breakdown of academic impact, for papers by Michelle Stewart